GPS Wealth Strategies Group’s Emergent Biosolutions EBS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $281 | Hold |
44
| – | – | ﹤0.01% | 1530 |
|
2025
Q1 | $214 | Hold |
44
| – | – | ﹤0.01% | 1427 |
|
2024
Q4 | $421 | Hold |
44
| – | – | ﹤0.01% | 1331 |
|
2024
Q3 | $367 | Hold |
44
| – | – | ﹤0.01% | 1341 |
|
2024
Q2 | $300 | Sell |
44
-18
| -29% | -$123 | ﹤0.01% | 1311 |
|
2024
Q1 | $157 | Hold |
62
| – | – | ﹤0.01% | 1222 |
|
2023
Q4 | $149 | Sell |
62
-760
| -92% | -$1.83K | ﹤0.01% | 1220 |
|
2023
Q3 | $2.8K | Hold |
822
| – | – | ﹤0.01% | 1076 |
|
2023
Q2 | $6.04K | Buy |
822
+44
| +6% | +$323 | ﹤0.01% | 949 |
|
2023
Q1 | $8.06K | Buy |
+778
| New | +$8.06K | ﹤0.01% | 874 |
|
2022
Q4 | – | Sell |
-18
| Closed | – | – | 390 |
|
2022
Q3 | $0 | Hold |
18
| – | – | ﹤0.01% | 1136 |
|
2022
Q2 | $1K | Hold |
18
| – | – | ﹤0.01% | 1059 |
|
2022
Q1 | $1K | Sell |
18
-54
| -75% | -$3K | ﹤0.01% | 990 |
|
2021
Q4 | $3K | Hold |
72
| – | – | ﹤0.01% | 939 |
|
2021
Q3 | $4K | Sell |
72
-256
| -78% | -$14.2K | ﹤0.01% | 860 |
|
2021
Q2 | $21K | Sell |
328
-209
| -39% | -$13.4K | 0.01% | 570 |
|
2021
Q1 | $49K | Buy |
+537
| New | +$49K | 0.01% | 383 |
|